US Patent

US12509443 — CSF-1R inhibitors and methods of use thereof

Formulation · Assigned to Deciphera Pharmaceuticals LLC · Expires 2045-04-30 · 19y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a pharmaceutical composition containing a compound of Formula (I) or its hydrate, essentially free of impurities, and methods of use thereof.

USPTO Abstract

Provided herein, in part, is a compound of Formula (I) or a hydrate thereof, essentially free of one or more impurities, compositions thereof, and methods of use thereof.

Drugs covered by this patent

Patent Metadata

Patent number
US12509443
Jurisdiction
US
Classification
Formulation
Expires
2045-04-30
Drug substance claim
No
Drug product claim
Yes
Assignee
Deciphera Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.